Machine learning-based coronary artery disease diagnosis: A comprehensive review.

Journal: Computers in biology and medicine
Published Date:

Abstract

Coronary artery disease (CAD) is the most common cardiovascular disease (CVD) and often leads to a heart attack. It annually causes millions of deaths and billions of dollars in financial losses worldwide. Angiography, which is invasive and risky, is the standard procedure for diagnosing CAD. Alternatively, machine learning (ML) techniques have been widely used in the literature as fast, affordable, and noninvasive approaches for CAD detection. The results that have been published on ML-based CAD diagnosis differ substantially in terms of the analyzed datasets, sample sizes, features, location of data collection, performance metrics, and applied ML techniques. Due to these fundamental differences, achievements in the literature cannot be generalized. This paper conducts a comprehensive and multifaceted review of all relevant studies that were published between 1992 and 2019 for ML-based CAD diagnosis. The impacts of various factors, such as dataset characteristics (geographical location, sample size, features, and the stenosis of each coronary artery) and applied ML techniques (feature selection, performance metrics, and method) are investigated in detail. Finally, the important challenges and shortcomings of ML-based CAD diagnosis are discussed.

Authors

  • Roohallah Alizadehsani
    Institute for Intelligent Systems Research and Innovation (IISRI), Deakin University, Geelong, Australia.
  • Moloud Abdar
    Département d'Informatique, Université du Québec à Montréal, Montréal, QC, Canada. m.abdar1987@gmail.com.
  • Mohamad Roshanzamir
    Department of Computer Engineering, Faculty of Engineering, Fasa University, Fasa, 74617-81189 Iran.
  • Abbas Khosravi
  • Parham M Kebria
    Institute for Intelligent Systems Research and Innovation (IISRI), Deakin University, Australia.
  • Fahime Khozeimeh
    Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Saeid Nahavandi
  • Nizal Sarrafzadegan
    Faculty of Medicine, SPPH, University of British Columbia, Vancouver, BC, Canada; Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Khorram Ave, Isfahan, Iran.
  • U Rajendra Acharya
    School of Business (Information Systems), Faculty of Business, Education, Law & Arts, University of Southern Queensland, Darling Heights, Australia.